Medicare Enrolled
Dr. Ed Atty, MD
Rehabilitation Practitioner · Flint, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Atty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Atty
Dr. Ed Atty is a rehabilitation practitioner in Flint, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Atty performed 8,377 Medicare services across 1,873 unique beneficiaries.
Between the years covered by Open Payments, Dr. Atty received a total of $5,720 from 45 pharmaceutical and/or device companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rehabilitation practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Atty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in MI
$5,720 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,377
Medicare services
Top 14% in MI for rehabilitation practitioner
1,873
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~419 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
2,981 | $1 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,738 | $83 | $240 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,026 | $0 | $5 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
641 | $0 | $1 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
325 | $194 | $406 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $59 | $165 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
232 | $61 | $189 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
161 | $10 | $30 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
152 | $79 | $320 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
95 | $144 | $797 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
80 | $153 | $354 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
78 | $476 | $2,682 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
78 | $261 | $1,377 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
67 | $195 | $860 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
67 | $185 | $1,046 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
67 | $97 | $523 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
60 | $40 | $157 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
60 | $111 | $354 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
48 | $84 | $341 |
| Lower back and sciatic nerve injection An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site. |
26 | $111 | $436 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
23 | $25 | $168 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
23 | $185 | $782 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
23 | $456 | $2,420 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
23 | $269 | $1,099 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
21 | $185 | $1,058 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
21 | $98 | $545 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,720
Total received (2018-2024)
Avg $953/year across 6 years
Top 25% in MI for rehabilitation practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
253
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,720 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$494
2023
$338
2022
$687
2021
$442
2019
$894
2018
$2,865
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$128
Merz Pharmaceuticals, LLC
$78
Ipsen Biopharmaceuticals, Inc
$61
Collegium Pharmaceutical, Inc.
$60
SPR Therapeutics, Inc
$35
Nevro Corp.
$34
SI-BONE, INC.
$27
SCILEX PHARMACEUTICALS INC.
$24
Boston Scientific Corporation
$24
Fidia Pharma USA Inc.
$24
Top 3 companies account for 53.9% of 2024 payments
All-time payments by company (2018-2024) ›
BOSTON SCIENTIFIC CORPORATION
$1,761
Collegium Pharmaceutical, Inc.
$265
Merz Pharmaceuticals, LLC
$240
Scilex Pharmaceuticals Inc.
$229
Merz North America, Inc.
$228
PFIZER INC.
$196
ABBVIE INC.
$192
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$159
Allergan Inc.
$150
Nevro Corp.
$147
Takeda Pharmaceuticals U.S.A., Inc.
$126
Ipsen Biopharmaceuticals, Inc
$123
Flexion Therapeutics, Inc.
$118
AbbVie Inc.
$100
Biohaven Pharmaceutical Holding Company Ltd.
$99
US WorldMeds, LLC
$97
Allergan, Inc.
$94
Fidia Pharma USA Inc.
$91
Pernix Therapeutics Holdings, Inc.
$91
Vertical Pharmaceuticals, LLC
$89
Abbott Laboratories
$88
GRT US Holding, Inc.
$70
Vertiflex, Inc.
$70
SCILEX PHARMACEUTICALS INC.
$62
Sentynl Therapeutics, Inc.
$62
Averitas Pharma Inc.
$60
ARBOR PHARMACEUTICALS, INC.
$59
BioDelivery Sciences International, Inc.
$58
Daiichi Sankyo Inc.
$57
Boston Scientific Corporation
$55
Amgen Inc.
$48
Medtronic, Inc.
$46
Electronic Waveform Lab, Inc.
$44
Medtronic USA, Inc.
$43
Bioventus LLC
$37
SPR Therapeutics, Inc
$35
FIDIA PHARMA USA INC.
$34
Egalet US Inc
$32
Teva Pharmaceuticals USA, Inc.
$29
SI-BONE, INC.
$27
SANOFI-AVENTIS U.S. LLC
$26
Virtus Pharmaceuticals LLC
$24
Avanir Pharmaceuticals, Inc.
$23
Kaleo, Inc.
$23
IBSA Pharma Inc.
$15
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · AUSTEDO · Aimovig · Amitiza · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · DYSPORT · Dysport · EMBEDA · EVZIO · Evzio · GELSYN-3 · HYALGAN · HYMOVIS · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · LEVORPHANOL TARTRATE · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · Licart · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · Morphabond ER · Movantik · NUEDEXTA · NURTEC ODT · NuDyn · Omnia · PROCLAIM · Proclaim Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELEXXII · RELISTOR · SCS IPGs · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SYNVISC-ONE · Senza · Supartz · Superion ISS · TREXIMET · UBRELVY · WaveWriter Alpha Prime 16 · XEOMIN · XIFIXAN · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rehabilitation practitioners within 10 mi
3
Per 100K population
0.7
County median income
$60,673
Nearest hospital
HURLEY MEDICAL CENTER
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Atty is a clinical cardiology specialist, with above-average Medicare volume (top 14% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Atty experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Atty performed 2,981 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atty receive payments from pharmaceutical companies?
Yes. Dr. Atty received a total of $5,720 from 45 companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atty's costs compare to other rehabilitation practitioners in Flint?
Dr. Atty's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rehabilitation Practitioners in Flint
Browse rehabilitation practitioners in Flint ranked by procedure volume and transparency data.
Highest volume
Top Rehabilitation Practitioners in MI
Rehabilitation practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rehabilitation Practitioners in MI
Which MI rehabilitation practitioners receive the most from drug and device companies.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Merz Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Merz Pharmaceuticals, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology